Philip W Shaul Selected Research

Sirtuin 1

1/2018

Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip W Shaul Research Topics

Disease

14	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2005
11	Atherosclerosis 01/2023 - 10/2002
8	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2008
7	Obesity 01/2024 - 08/2014
7	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2023 - 01/2011
7	Thrombosis (Thrombus) 10/2023 - 06/2006
6	Insulin Resistance 12/2023 - 03/2013
5	Neoplasms (Cancer) 11/2018 - 04/2011
5	Lung Diseases (Lung Disease) 01/2006 - 05/2003
4	Hypertension (High Blood Pressure) 12/2019 - 01/2002
4	Vascular Diseases (Vascular Disease) 07/2014 - 02/2003
3	Body Weight (Weight, Body) 01/2024 - 02/2011
3	Inflammation (Inflammations) 01/2023 - 01/2018
3	Pregnancy Complications 03/2016 - 01/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2016 - 06/2009
3	Neointima 01/2015 - 09/2014
3	Bronchopulmonary Dysplasia 07/2011 - 01/2006
3	Premature Birth (Birth, Premature) 02/2011 - 03/2005
2	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 01/2011
2	Sepsis (Septicemia) 08/2023 - 01/2022
2	Hypercholesterolemia 01/2023 - 10/2007
2	Infarction (Infarctions) 11/2018 - 01/2017
2	Hemorrhage 09/2017 - 02/2011
2	Patent Ductus Arteriosus 03/2011 - 12/2005
2	Pneumonia (Pneumonitis) 03/2011 - 03/2009
2	Electric Injuries 05/2007 - 01/2006
2	Vascular System Injuries 08/2003 - 10/2002
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022
1	Encephalomyelitis (Myeloencephalitis) 01/2021
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Myocardial Infarction 01/2019
1	Neuroinflammatory Diseases 11/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2018
1	Stroke (Strokes) 11/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Weight Gain 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Infections 10/2017
1	Reperfusion Injury 01/2017

Drug/Important Bio-Agent (IBA)

10	Estrogens (Estrogen)FDA Link 01/2023 - 10/2002
9	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 03/2013
8	CholesterolIBA 01/2023 - 06/2006
8	C-Reactive ProteinIBA 01/2016 - 11/2005
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2011 - 02/2003
6	low density lipoprotein receptor-related protein 8IBA 01/2021 - 09/2014
6	Estradiol (Delestrogen)FDA LinkGeneric 11/2018 - 03/2009
6	Antiphospholipid AntibodiesIBA 10/2018 - 01/2011
6	Nitric Oxide Synthase (NO Synthase)IBA 02/2015 - 02/2003
5	Insulin (Novolin)FDA Link 12/2023 - 06/2009
5	27-hydroxycholesterolIBA 01/2023 - 10/2007
5	Estrogen ReceptorsIBA 03/2022 - 10/2007
5	HDL CholesterolIBA 05/2015 - 02/2004
4	Immunoglobulin G (IgG)IBA 12/2019 - 10/2014
4	Scavenger Receptors (Scavenger Receptor)IBA 01/2019 - 08/2003
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2018 - 02/2003
4	Apolipoproteins E (ApoE)IBA 10/2016 - 07/2014
4	HDL LipoproteinsIBA 12/2014 - 08/2003
4	EnzymesIBA 11/2013 - 05/2007
3	IgG Receptors (Fc gamma RI)IBA 12/2019 - 02/2015
3	LigandsIBA 01/2018 - 11/2013
3	Estrogen Receptor alphaIBA 01/2017 - 07/2010
3	Selective Estrogen Receptor Modulators (SERM)IBA 08/2014 - 01/2008
3	high density lipoprotein receptorsIBA 10/2012 - 08/2003
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2009 - 11/2005
2	GlucocorticoidsIBA 08/2023 - 01/2022
2	LipidsIBA 01/2023 - 07/2014
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2019 - 01/2018
2	N-acetylmannosamineIBA 12/2019 - 01/2018
2	Glycoproteins (Glycoprotein)IBA 10/2018 - 01/2011
2	Dendrimers (Dendrons)IBA 10/2016 - 04/2011
2	LDL Receptors (LDL Receptor)IBA 03/2016 - 03/2016
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2006 - 08/2003
2	Surface-Active Agents (Surfactants)IBA 01/2006 - 12/2005
2	acivicin (AT 125)IBA 03/2005 - 05/2003
1	Glucagon (Glukagon)FDA Link 12/2023
1	fibroblast growth factor 21IBA 12/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2023
1	Carrier Proteins (Binding Protein)IBA 10/2023
1	AntibodiesIBA 10/2023
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	(S)- 5- (4- hydroxy- 3,5- dimethyl- phenyl)- indan- 1- olIBA 11/2018
1	Sirtuin 1IBA 01/2018
1	CollagenIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 01/2018
1	ResveratrolIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2017
1	AminesIBA 10/2016

Therapy/Procedure

6	Therapeutics 08/2023 - 05/2007
5	Ligation 08/2023 - 12/2005
2	Punctures 08/2023 - 01/2022
1	Bariatric Surgery 01/2024
1	Caloric Restriction 01/2024
1	Precision Medicine 01/2022